Financials
- Fiscal year
- 2023
- Total assets
- €1.7m
- Profit
- €122,899
- Solvency
- 66.4%
Total assets▲ 3.9%
Net result
20182023
LT Pharma
ActiveSummary
For LT Pharma, at least two filing cycles of the annual accounts are missing. The 2023 annual accounts show equity of €1.1m and a net result of €122,899. Equity is growing by ~15.2% per year across the filed fiscal years. Its solvency ranks better than 84% of 6609 sector peers (fiscal year 2023). The company has been active since 2016 and the Belgian State Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 1.2% (low).
Overview
What they do
Retail sale of pharmaceutical products
NACE 47730
1 site
How big
€1.7mtotal assets 2023
- Equity
- €1.1m
- Profit
- €122,899
Financially healthy?
- Bankruptcy chance 12 m
- 1.2%
2023 figures too old to score
Who decides
Accounts 428 d overdue0 of 2 deeds read
Signals- Higher-failure-rate sector- Annual accounts: weaker financial profile- Higher-failure-rate region- Two or more financial years not filedFiled after the deadlineShow the evidence
Checked score
No current score
Figures too old
The available figures for FY 2023 are too old to assess current financial health.
Filing: At least two filing cycles are missing
Axes, FY 2023 · tick = 2022
Profitability78▼-1
Solvency91▲+5
Growth52=
Track record100
Bankruptcy probability, 12 months
1.2%
Low
0%0.5%1.5%4%10%≥ 25%
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2023Solvency, return and age of the figures
Solvency
66.4%
Return on assets
7.3%
Age of the figures
33 mo
raises risk · Two or more financial years not filed
Since the financial year that closed on 31-12-2024, 2 financial years are missing at the National Bank. A company this far behind goes bankrupt within the year nineteen times as often as a punctual filer.
NBB · 7 filingsPosition against the passed deadline
31-12-2024 close31-07-2025 deadline02-10-2026 today
neutral · Filed after the deadline
The financial year that closed on 31-12-2023 was due by 31-07-2024 and was filed on 31-08-2024, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 7 filingsDeviation from the deadline
2025
not confirmed
2024
not filed
2023
31 d late
2022
32 d late
2021
31 d late
2020
30 d late
2019
153 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 5 accounts on average 55 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.
Checked, nothing found (1)
- Annual accounts filedfiscal year 2023 · full…
- Equity above €1mEq €1.1m ▲12.4%
- Annual accounts filedfiscal year 2022 · full…
Key points
By topic
Timeline
- Events
- 11
- Since
- 2018
- 31-08-2024Annual accounts filed
- 31-12-2023Equity above €1m
- 01-09-2023Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Founded
- 08-09-2016
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.